Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan;185(1):219-222.
doi: 10.1002/ajmg.a.61916. Epub 2020 Oct 15.

Epilepsy and movement disorders in CDG: Report on the oldest-known MOGS-CDG patient

Tommaso Lo Barco  1   2 , Elisa Osanni  3 , Andrea Bordugo  4 , Giulia Rodella  4 , Maria Iascone  5 , Romano Tenconi  6 , Rita Barone  7 , Bernardo Dalla Bernardina  8 , Gaetano Cantalupo  1
Affiliations
Case Reports

Epilepsy and movement disorders in CDG: Report on the oldest-known MOGS-CDG patient

Tommaso Lo Barco et al. Am J Med Genet A. 2021 Jan.

Abstract

Congenital glycosylation disorders (CDG) are inherited metabolic diseases due to defective glycoprotein and glycolipid glycan assembly and attachment. MOGS-CDG is a rare disorder with seven patients from five families reported worldwide. We report on a 19-year-old girl with MOGS-CDG. At birth she presented facial dysmorphism, marked hypotonia, and drug-resistant tonic seizures. In the following months, her motility was strongly limited by dystonia, with forced posture of the head and of both hands. She showed a peculiar hyperkinetic movement disorder with a rhythmic and repetitive pattern repeatedly documented on EEG-polygraphy recordings. Brain MRI showed progressive cortical and subcortical atrophy. Epileptic spasms appeared in first months and ceased by the age of 7 years, while tonic seizures were still present at last assessment (19 years). We report the oldest-known MOGS-CDG patient and broaden the neurological phenotype of this CDG.

Keywords: MOGS; congenital disorders of glycosylation; long-term outcome; movement disorders; spasms.

PubMed Disclaimer

References

REFERENCES

    1. de Praeter, C. M., Gerwig, G. J., Bause, E., Nuytinck, L. K., Vliegenthart, J. F. G., Breuer, W., … van Coster, R. N. (2000). A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. American Journal of Human Genetics, 66, 1744-1756.
    1. Fiumara, A., Barone, R., del Campo, G., Striano, P., & Jaeken, J. (2016). Electroclinical features of early-onset epileptic encephalopathies in congenital disorders of glycosylation (CDGs). JIMD Reports, 27, 93-99.
    1. Jaeken, J., & van den Heuvel, L. (2014). Congenital disorders of glycosilation. In Physician's guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases (pp. 484-511). Berlin, Heidelberg: Springer.
    1. Jaeken, J., Lefeber, D. J., & Matthijs, G. (2020). SRD5A3 defective congenital disorder of glycosylation: Clinical utility gene card. European Journal of Human Genetics, 28, 1297-1300.
    1. Kane, M. S., Davids, M., Adams, C., Wolfe, L. A., Cheung, H. W., Gropman, A., … Boerkoel, C. F. (2016). Mitotic intragenic recombination: A mechanism of survival for several congenital disorders of glycosylation. American Journal of Human Genetics, 98, 339-346.

Publication types

MeSH terms